Armstrong, A. W., Lebwohl, M., Warren, R. B., Sofen, H., Imafuku, S., Ohtsuki, M., Spelman, L., Passeron, T., Papp, K. A., Kisa, R. M., Berger, V., Vritzali, E., Hoyt, K., Colombo, M. J., Banerjee, S., Strober, B., Thaçi, D., & Blauvelt, A. (2023). Deucravacitinib in Plaque Psoriasis: 3-Year Safety and Efficacy Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials. SKIN The Journal of Cutaneous Medicine, 7(6), s240. https://doi.org/10.25251/skin.7.supp.240